1. Home
  2. HNNA vs RPTX Comparison

HNNA vs RPTX Comparison

Compare HNNA & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hennessy Advisors Inc.

HNNA

Hennessy Advisors Inc.

HOLD

Current Price

$10.54

Market Cap

78.2M

Sector

Finance

ML Signal

HOLD

Logo Repare Therapeutics Inc.

RPTX

Repare Therapeutics Inc.

HOLD

Current Price

$2.62

Market Cap

92.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HNNA
RPTX
Founded
1989
2016
Country
United States
Canada
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
78.2M
92.4M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
HNNA
RPTX
Price
$10.54
$2.62
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
26.7K
1.7M
Earning Date
02-12-2026
03-02-2026
Dividend Yield
5.32%
N/A
EPS Growth
38.04
N/A
EPS
1.27
N/A
Revenue
$35,538,000.00
$11,870,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2,122.22
P/E Ratio
$8.14
N/A
Revenue Growth
19.88
N/A
52 Week Low
$8.43
$0.89
52 Week High
$13.19
$2.66

Technical Indicators

Market Signals
Indicator
HNNA
RPTX
Relative Strength Index (RSI) 65.34 68.79
Support Level $10.01 $2.50
Resistance Level $10.48 $2.61
Average True Range (ATR) 0.28 0.04
MACD 0.09 -0.01
Stochastic Oscillator 95.08 76.00

Price Performance

Historical Comparison
HNNA
RPTX

About HNNA Hennessy Advisors Inc.

Hennessy Advisors Inc is an investment management company that manages and markets open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, multi-asset sectors, specialty products, and fixed income products. The company earns revenues mainly from investment advisory services and secondarily from shareholder services. Advisory services include managing each fund's portfolio in line with its investment objectives, monitoring compliance and performance, overseeing sub-advisors and other service providers, and handling marketing, distribution, and regulatory reporting. Shareholder services cover investor support and coordination with the fund service provider, with all related fees based on the funds' average daily net asset values.

About RPTX Repare Therapeutics Inc.

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.

Share on Social Networks: